ID   PPMNT_MYCTU             Reviewed;         874 AA.
AC   O53493; F2GDY6; I6Y888; L0TBC5;
DT   11-NOV-2015, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   07-APR-2021, entry version 138.
DE   RecName: Full=Bifunctional apolipoprotein N-acyltransferase/polyprenol monophosphomannose synthase;
DE   Includes:
DE     RecName: Full=Apolipoprotein N-acyltransferase {ECO:0000303|PubMed:19661058};
DE              Short=ALP N-acyltransferase {ECO:0000250|UniProtKB:P23930};
DE              EC=2.3.1.269 {ECO:0000269|PubMed:12427759};
DE   Includes:
DE     RecName: Full=Polyprenol monophosphomannose synthase {ECO:0000303|PubMed:11931640};
DE              Short=PPM synthase {ECO:0000303|PubMed:11931640};
DE              Short=Polyprenol-P-Man synthase {ECO:0000303|PubMed:12427759};
DE              Short=Ppm1 {ECO:0000303|PubMed:11931640};
DE              EC=2.4.1.- {ECO:0000269|PubMed:11931640};
DE     AltName: Full=Dolichol-phosphate mannose synthase;
DE              EC=2.4.1.83 {ECO:0000269|PubMed:11931640};
GN   Name=ppm1 {ECO:0000303|PubMed:11931640};
GN   Synonyms=lnt {ECO:0000305|PubMed:19661058}; OrderedLocusNames=Rv2051c;
OS   Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv).
OC   Bacteria; Actinobacteria; Corynebacteriales; Mycobacteriaceae;
OC   Mycobacterium; Mycobacterium tuberculosis complex.
OX   NCBI_TaxID=83332;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=9634230; DOI=10.1038/31159;
RA   Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C.M., Harris D.E.,
RA   Gordon S.V., Eiglmeier K., Gas S., Barry C.E. III, Tekaia F., Badcock K.,
RA   Basham D., Brown D., Chillingworth T., Connor R., Davies R.M., Devlin K.,
RA   Feltwell T., Gentles S., Hamlin N., Holroyd S., Hornsby T., Jagels K.,
RA   Krogh A., McLean J., Moule S., Murphy L.D., Oliver S., Osborne J.,
RA   Quail M.A., Rajandream M.A., Rogers J., Rutter S., Seeger K., Skelton S.,
RA   Squares S., Squares R., Sulston J.E., Taylor K., Whitehead S.,
RA   Barrell B.G.;
RT   "Deciphering the biology of Mycobacterium tuberculosis from the complete
RT   genome sequence.";
RL   Nature 393:537-544(1998).
RN   [2]
RP   FUNCTION AS A PHOSPHOMANNOSE SYNTHASE, CATALYTIC ACTIVITY, SUBSTRATE
RP   SPECIFICITY, DOMAIN, AND EXPRESSION IN M.SMEGMATIS.
RX   PubMed=11931640; DOI=10.1042/bj20020107;
RA   Gurcha S.S., Baulard A.R., Kremer L., Locht C., Moody D.B., Muhlecker W.,
RA   Costello C.E., Crick D.C., Brennan P.J., Besra G.S.;
RT   "Ppm1, a novel polyprenol monophosphomannose synthase from Mycobacterium
RT   tuberculosis.";
RL   Biochem. J. 365:441-450(2002).
RN   [3]
RP   SUBCELLULAR LOCATION, DOMAIN, AND TOPOLOGY.
RX   PubMed=12427759; DOI=10.1074/jbc.m207922200;
RA   Baulard A.R., Gurcha S.S., Engohang-Ndong J., Gouffi K., Locht C.,
RA   Besra G.S.;
RT   "In vivo interaction between the polyprenol phosphate mannose synthase Ppm1
RT   and the integral membrane protein Ppm2 from Mycobacterium smegmatis
RT   revealed by a bacterial two-hybrid system.";
RL   J. Biol. Chem. 278:2242-2248(2003).
RN   [4]
RP   FUNCTION AS AN N-ACYLTRANSFERASE.
RX   PubMed=19661058; DOI=10.1074/jbc.m109.022715;
RA   Tschumi A., Nai C., Auchli Y., Hunziker P., Gehrig P., Keller P., Grau T.,
RA   Sander P.;
RT   "Identification of apolipoprotein N-acyltransferase (Lnt) in
RT   mycobacteria.";
RL   J. Biol. Chem. 284:27146-27156(2009).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=21969609; DOI=10.1074/mcp.m111.011627;
RA   Kelkar D.S., Kumar D., Kumar P., Balakrishnan L., Muthusamy B., Yadav A.K.,
RA   Shrivastava P., Marimuthu A., Anand S., Sundaram H., Kingsbury R.,
RA   Harsha H.C., Nair B., Prasad T.S., Chauhan D.S., Katoch K., Katoch V.M.,
RA   Kumar P., Chaerkady R., Ramachandran S., Dash D., Pandey A.;
RT   "Proteogenomic analysis of Mycobacterium tuberculosis by high resolution
RT   mass spectrometry.";
RL   Mol. Cell. Proteomics 10:M111.011627-M111.011627(2011).
CC   -!- FUNCTION: Catalyzes the phospholipid dependent N-acylation of the N-
CC       terminal cysteine of apolipoprotein, the last step in lipoprotein
CC       maturation. {ECO:0000269|PubMed:19661058}.
CC   -!- FUNCTION: Transfers mannose from GDP-mannose to lipid acceptors (works
CC       best on C20-C95 lipid monophosphate substrates in which the lipid can
CC       be modified, tested with the C-terminal domain expressed in
CC       M.smegmatis) to form polyprenol monophosphomannose (PPM). PMM is an
CC       alkai-stable sugar donor which adds mannose-phosphate residues to
CC       triacylated-phosphatidyl-myo-inositol mannosides (PIM2), eventually
CC       leading to generation of the cell wall glycolipid lipoglycan modulins
CC       lipoarabinomannan (LAM) and lipomannan (LM).
CC       {ECO:0000269|PubMed:11931640}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a glycerophospholipid + N-terminal S-1,2-diacyl-sn-glyceryl-L-
CC         cysteinyl-[lipoprotein] = a 1-lyso-glycerophospholipid + H(+) + N-
CC         acyl-S-1,2-diacyl-sn-glyceryl-L-cysteinyl-[lipoprotein];
CC         Xref=Rhea:RHEA:48228, Rhea:RHEA-COMP:14681, Rhea:RHEA-COMP:14684,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:136912, ChEBI:CHEBI:140656,
CC         ChEBI:CHEBI:140657, ChEBI:CHEBI:140660; EC=2.3.1.269;
CC         Evidence={ECO:0000269|PubMed:19661058};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=dolichyl phosphate + GDP-alpha-D-mannose = dolichyl beta-D-
CC         mannosyl phosphate + GDP; Xref=Rhea:RHEA:21184, Rhea:RHEA-COMP:9517,
CC         Rhea:RHEA-COMP:9527, ChEBI:CHEBI:57527, ChEBI:CHEBI:57683,
CC         ChEBI:CHEBI:58189, ChEBI:CHEBI:58211; EC=2.4.1.83;
CC         Evidence={ECO:0000269|PubMed:11931640};
CC   -!- PATHWAY: Protein modification; lipoprotein biosynthesis (N-acyl
CC       transfer).
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:12427759};
CC       Multi-pass membrane protein {ECO:0000255}.
CC   -!- DOMAIN: Consists of 2 domains; the N-terminus (residues 1-593) probably
CC       has the N-acyltransferase activity while the C-terminus (residues 594-
CC       874) has polyprenol monophosphomannose (PPM) synthase activity. The
CC       whole protein has higher PPM synthase than the second domain alone when
CC       expressed in M.smegmatis, suggesting the N-acyltransferase domain plays
CC       a stimulating role in PPM synthesis. {ECO:0000269|PubMed:11931640,
CC       ECO:0000269|PubMed:12427759}.
CC   -!- MISCELLANEOUS: In a number of other Mycobacteria, including M.avis,
CC       M.leprae and M.smegmatis, these domains are encoded by 2 separate
CC       adjacent genes. {ECO:0000305|PubMed:11931640}.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the CN hydrolase
CC       family. Apolipoprotein N-acyltransferase subfamily.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the
CC       glycosyltransferase 2 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL123456; CCP44824.1; -; Genomic_DNA.
DR   RefSeq; NP_216567.1; NC_000962.3.
DR   RefSeq; WP_003902238.1; NZ_NVQJ01000047.1.
DR   SMR; O53493; -.
DR   STRING; 83332.Rv2051c; -.
DR   CAZy; GT2; Glycosyltransferase Family 2.
DR   PaxDb; O53493; -.
DR   PRIDE; O53493; -.
DR   GeneID; 887402; -.
DR   KEGG; mtu:Rv2051c; -.
DR   PATRIC; fig|83332.111.peg.2287; -.
DR   TubercuList; Rv2051c; -.
DR   eggNOG; COG0463; Bacteria.
DR   eggNOG; COG0815; Bacteria.
DR   OMA; ADEMPND; -.
DR   BioCyc; MetaCyc:G185E-6255-MONOMER; -.
DR   UniPathway; UPA00666; -.
DR   Proteomes; UP000001584; Chromosome.
DR   GO; GO:0005618; C:cell wall; HDA:MTBBASE.
DR   GO; GO:0005829; C:cytosol; HDA:MTBBASE.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; HDA:MTBBASE.
DR   GO; GO:0004582; F:dolichyl-phosphate beta-D-mannosyltransferase activity; IDA:MTBBASE.
DR   GO; GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW.
DR   GO; GO:0016410; F:N-acyltransferase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0009247; P:glycolipid biosynthetic process; IDA:MTBBASE.
DR   GO; GO:0042158; P:lipoprotein biosynthetic process; IEA:UniProtKB-UniRule.
DR   GO; GO:0052553; P:modulation by symbiont of host immune response; IDA:MTBBASE.
DR   CDD; cd07571; ALP_N-acyl_transferase; 1.
DR   CDD; cd06442; DPM1_like; 1.
DR   Gene3D; 3.60.110.10; -; 1.
DR   Gene3D; 3.90.550.10; -; 1.
DR   HAMAP; MF_01148; Lnt; 1.
DR   InterPro; IPR004563; Apolipo_AcylTrfase.
DR   InterPro; IPR003010; C-N_Hydrolase.
DR   InterPro; IPR036526; C-N_Hydrolase_sf.
DR   InterPro; IPR039528; DPM1-like.
DR   InterPro; IPR001173; Glyco_trans_2-like.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   PANTHER; PTHR43398; PTHR43398; 1.
DR   Pfam; PF00795; CN_hydrolase; 1.
DR   Pfam; PF00535; Glycos_transf_2; 1.
DR   SUPFAM; SSF53448; SSF53448; 1.
DR   SUPFAM; SSF56317; SSF56317; 1.
DR   TIGRFAMs; TIGR00546; lnt; 1.
DR   PROSITE; PS50263; CN_HYDROLASE; 1.
PE   1: Evidence at protein level;
KW   Acyltransferase; Cell membrane; Glycosyltransferase; Hydrolase; Membrane;
KW   Reference proteome; Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN           1..874
FT                   /note="Bifunctional apolipoprotein N-
FT                   acyltransferase/polyprenol monophosphomannose synthase"
FT                   /id="PRO_0000434582"
FT   TOPO_DOM        1..22
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:A0QZ13"
FT   TRANSMEM        23..42
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:A0QZ13"
FT   TOPO_DOM        43..71
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:A0QZ13"
FT   TRANSMEM        72..89
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:A0QZ13"
FT   TOPO_DOM        90..93
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:A0QZ13"
FT   TRANSMEM        94..115
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:A0QZ13"
FT   TOPO_DOM        116..176
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:A0QZ13"
FT   TRANSMEM        177..194
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:A0QZ13"
FT   TOPO_DOM        195..205
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:A0QZ13"
FT   TRANSMEM        206..223
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:A0QZ13"
FT   TOPO_DOM        224..508
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305|PubMed:12427759"
FT   TRANSMEM        509..526
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:A0QZ13"
FT   TOPO_DOM        527..874
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:12427759"
FT   DOMAIN          241..497
FT                   /note="CN hydrolase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00054"
FT   REGION          1..593
FT                   /note="Apolipoprotein N-acyltransferase"
FT   REGION          594..874
FT                   /note="Polyprenol monophosphomannose synthase"
FT                   /evidence="ECO:0000269|PubMed:11931640"
FT   ACT_SITE        294
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00054"
FT   ACT_SITE        359
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00054"
FT   ACT_SITE        409
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00054"
SQ   SEQUENCE   874 AA;  93824 MW;  E00EADD2EC3238B4 CRC64;
     MKLGAWVAAQ LPTTRTAVRT RLTRLVVSIV AGLLLYASFP PRNCWWAAVV ALALLAWVLT
     HRATTPVGGL GYGLLFGLVF YVSLLPWIGE LVGPGPWLAL ATTCALFPGI FGLFAVVVRL
     LPGWPIWFAV GWAAQEWLKS ILPFGGFPWG SVAFGQAEGP LLPLVQLGGV ALLSTGVALV
     GCGLTAIALE IEKWWRTGGQ GDAPPAVVLP AACICLVLFA AIVVWPQVRH AGSGSGGEPT
     VTVAVVQGNV PRLGLDFNAQ RRAVLDNHVE ETLRLAADVH AGLAQQPQFV IWPENSSDID
     PFVNPDAGQR ISAAAEAIGA PILIGTLMDV PGRPRENPEW TNTAIVWNPG TGPADRHDKA
     IVQPFGEYLP MPWLFRHLSG YADRAGHFVP GNGTGVVRIA GVPVGVATCW EVIFDRAPRK
     SILGGAQLLT VPSNNATFNK TMSEQQLAFA KVRAVEHDRY VVVAGTTGIS AVIAPDGGEL
     IRTDFFQPAY LDSQVRLKTR LTPATRWGPI LQWILVGAAA AVVLVAMRQN GWFPRPRRSE
     PKGENDDSDA PPGRSEASGP PALSESDDEL IQPEQGGRHS SGFGRHRATS RSYMTTGQPA
     PPAPGNRPSQ RVLVIIPTFN ERENLPVIHR RLTQACPAVH VLVVDDSSPD GTGQLADELA
     QADPGRTHVM HRTAKNGLGA AYLAGFAWGL SREYSVLVEM DADGSHAPEQ LQRLLDAVDA
     GADLAIGSRY VAGGTVRNWP WRRLVLSKTA NTYSRLALGI GIHDITAGYR AYRREALEAI
     DLDGVDSKGY CFQIDLTWRT VSNGFVVTEV PITFTERELG VSKMSGSNIR EALVKVARWG
     IEGRLSRSDH ARARPDIARP GAGGSRVSRA DVTE
//
